跳至主要内容
临床试验/ISRCTN35114412
ISRCTN35114412已完成不适用

Clopidogrel as prophylactic treatment for migraine

Guy's and St Thomas NHS Trust (UK)0 个研究点目标入组 286 人开始时间: 2008年4月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
286

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age greater than 18 years, either sex
  • 2. Migraine as defined by International Headache Criteria
  • 3. More than two attacks in 28 days

排除标准

  • 1. High risk features suggesting cerebral malignancy
  • 2. Contra-indications to clopidogrel
  • 3. Requirements for routine non-steroidal anti-inflammatory agent or aspirin other than for acute headache
  • 4. Use of an investigational product within three months
  • 5. Inability to understand English
  • 6. Pregnancy or breast-feeding
  • 7. Abnormal platelet or liver function

研究者

发起方
Guy's and St Thomas NHS Trust (UK)

相似试验